192 related articles for article (PubMed ID: 36978083)
1. Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus.
Ghobadi MZ; Afsaneh E; Emamzadeh R; Soroush M
BMC Med Genomics; 2023 Mar; 16(1):62. PubMed ID: 36978083
[TBL] [Abstract][Full Text] [Related]
2. Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning.
Ghobadi MZ; Emamzadeh R; Afsaneh E
BMC Cancer; 2022 Apr; 22(1):433. PubMed ID: 35449091
[TBL] [Abstract][Full Text] [Related]
3. Gene biomarkers and classifiers for various subtypes of HTLV-1-caused ATLL cancer identified by a combination of differential gene co‑expression and support vector machine algorithms.
Zarei Ghobadi M; Afsaneh E; Emamzadeh R
Med Microbiol Immunol; 2023 Aug; 212(4):263-270. PubMed ID: 37222763
[TBL] [Abstract][Full Text] [Related]
4. Signaling factors potentially associated to the pathogenesis of Adult T-cell leukemia /lymphoma: A network-analysis and novel findings assessment.
Mozhgani SH; Zarei Ghobadi M; Norouzi M; Rahimi H; Valizadeh N; Teymoori-Rad M; Tarokhian H; Ostadali M; Farajifard H; Rezaee SA
Virus Res; 2022 Oct; 319():198875. PubMed ID: 35868352
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes.
Shayeghpour A; Forghani-Ramandi MM; Solouki S; Hosseini A; Hosseini P; Khodayar S; Hasani M; Aghajanian S; Siami Z; Zarei Ghobadi M; Mozhgani SH
Infect Agent Cancer; 2023 Feb; 18(1):12. PubMed ID: 36841815
[TBL] [Abstract][Full Text] [Related]
6. Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
Zarei Ghobadi M; Emamzadeh R
PLoS One; 2022; 17(1):e0262739. PubMed ID: 35041720
[TBL] [Abstract][Full Text] [Related]
7. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
Amano M; Kurokawa M; Ogata K; Itoh H; Kataoka H; Setoyama M
J Dermatol; 2008 May; 35(5):270-5. PubMed ID: 18477226
[TBL] [Abstract][Full Text] [Related]
8. Deciphering microRNA-mRNA regulatory network in adult T-cell leukemia/lymphoma; the battle between oncogenes and anti-oncogenes.
Ghobadi MZ; Emamzadeh R; Mozhgani SH
PLoS One; 2021; 16(2):e0247713. PubMed ID: 33630973
[TBL] [Abstract][Full Text] [Related]
9. Random integration of HTLV-1 provirus: increasing chromosomal instability.
Ohshima K; Ohgami A; Matsuoka M; Etoh K; Utsunomiya A; Makino T; Ishiguro M; Suzumiya J; Kikuchi M
Cancer Lett; 1998 Oct; 132(1-2):203-12. PubMed ID: 10397475
[TBL] [Abstract][Full Text] [Related]
10. MiR-150 in HTLV-1 infection and T-cell transformation.
D'Agostino DM; Raimondi V; Silic-Benussi M; Ciminale V
Front Immunol; 2022; 13():974088. PubMed ID: 36072598
[TBL] [Abstract][Full Text] [Related]
11. Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region.
Ashrafi F; Rahimzada M; Parandi M; Mirhosseini A; Mashkani B; Ahmadi Ghezeldasht S; Soltani A; Rafatpanah H; Mosavat A; Abdolrahim Rezaee S
Gene; 2022 Dec; 847():146885. PubMed ID: 36108787
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
13. Global expression of noncoding RNome reveals dysregulation of small RNAs in patients with HTLV-1-associated adult T-cell leukemia: a pilot study.
Nascimento A; Valadão de Souza DR; Pessôa R; Pietrobon AJ; Nukui Y; Pereira J; Casseb J; Penalva de Oliveira AC; Loureiro P; da Silva Duarte AJ; Clissa PB; Sanabani SS
Infect Agent Cancer; 2021 Jan; 16(1):4. PubMed ID: 33422115
[TBL] [Abstract][Full Text] [Related]
14. Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study.
Zarei Ghobadi M; Emamzadeh R; Teymoori-Rad M; Mozhgani SH
Virol J; 2021 Aug; 18(1):175. PubMed ID: 34446027
[TBL] [Abstract][Full Text] [Related]
15. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
Nakahata S; Morishita K
J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
[TBL] [Abstract][Full Text] [Related]
16. HTLV-1 and associated adult T-cell leukemia/lymphoma.
Mahieux R; Gessain A
Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
[TBL] [Abstract][Full Text] [Related]
18. Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma.
Aguilar C; Beltran BE; Morales D; Gutiérrez-Garibay M; Villela L; Marques-Piubelli ML; Vega F; Miranda RN; Malpica L
Cardiovasc Pathol; 2023; 64():107513. PubMed ID: 36567046
[TBL] [Abstract][Full Text] [Related]
19. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
Kozako T; Yoshimitsu M; Fujiwara H; Masamoto I; Horai S; White Y; Akimoto M; Suzuki S; Matsushita K; Uozumi K; Tei C; Arima N
Leukemia; 2009 Feb; 23(2):375-82. PubMed ID: 18830259
[TBL] [Abstract][Full Text] [Related]
20. Clinical and cytopathological characteristics of HTLV-1
Kobata K; Kimura S; Mihashi Y; Iwasaki H; Nonaka S; Matsumoto S; Takamatsu Y; Choi I; Kawauchi S; Ishitsuka K; Takeshita M
Cancer Med; 2020 Aug; 9(16):5788-5797. PubMed ID: 32597011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
